JUBLPHARMA — Jubilant Pharmova Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Jubilant Pharmova, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	8,711	6,304	278	1,705	9,806
Depreciation
Non-Cash Items	6,058	1,978	2,288	3,735	-1,505
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-2,212	-3,724	-1,500	454	-1,266
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	17,073	8,375	6,607	9,713	10,721
Capital Expenditures	-5,275	-6,000	-8,144	-8,977	-11,156
Purchase of Fixed Assets
Other Investing Cash Flow Items	-2,115	2,196	2,700	2,898	16,033
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-7,390	-3,804	-5,444	-6,079	4,877
Financing Cash Flow Items	-2,922	-1,349	-2,342	-2,437	-2,356
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-17,094	-326	-1,567	-4,325	-14,527
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-7,289	4,819	301	-575	1,319